BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11264775)

  • 1. Dialysis-related amyloidosis after renal transplantation.
    Campistol JM
    Semin Dial; 2001; 14(2):99-102. PubMed ID: 11264775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis-related amyloidosis: history and clinical manifestations.
    Danesh F; Ho LT
    Semin Dial; 2001; 14(2):80-5. PubMed ID: 11264771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy.
    Jadoul M; Malghem J; Pirson Y; Maldague B; van Ypersele de Strihou C
    Clin Nephrol; 1989 Oct; 32(4):194-7. PubMed ID: 2680195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis-associated amyloidosis and beta-2 microglobulin. Clinical and immunohistochemical study.
    Bardin T; Zingraff J; Shirahama T; Noel LH; Droz D; Voisin MC; Drueke T; Dryll A; Skinner M; Cohen AS
    Am J Med; 1987 Sep; 83(3):419-24. PubMed ID: 3310621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural involvement of dialysis-related amyloidosis.
    Suzuki M; Betsuyaku T; Kojima T; Saito H; Nishiura Y; Fukasawa Y; Nishimura M; Kawakami Y
    Intern Med; 2005 Jun; 44(6):628-31. PubMed ID: 16020894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis arthropathy: outcome after renal transplantation.
    Bardin T; Lebail-Darné JL; Zingraff J; Laredo JD; Voisin MC; Kreis H; Kuntz D
    Am J Med; 1995 Sep; 99(3):243-8. PubMed ID: 7653483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of β(2)-microglobulin adsorption column in treating dialysis-related amyloidosis: a multicenter study.
    Kuragano T; Inoue T; Yoh K; Shin J; Fujita Y; Yoshiya K; Kim JI; Sakai R; Sekita K; Goto T; Fukagawa M; Nakanishi T
    Blood Purif; 2011; 32(4):317-22. PubMed ID: 21934303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J; Floege J; Ehlerding G; Koch KM
    Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of beta 2-microglobulin amyloid 10 years after renal transplantation.
    Kessler M; Aymard B; Pourel J
    Nephrol Dial Transplant; 1994; 9(3):333-4. PubMed ID: 8052450
    [No Abstract]   [Full Text] [Related]  

  • 13. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach.
    Cianciolo G; Colí L; La Manna G; Donati G; D'Addio F; Comai G; Ricci D; Dormi A; Wratten M; Feliciangeli G; Stefoni S
    Int J Artif Organs; 2007 Oct; 30(10):864-78. PubMed ID: 17992647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does dialysis-associated amyloidosis resolve after transplantation?
    Nelson SR; Sharpstone P; Kingswood JC
    Nephrol Dial Transplant; 1993; 8(4):369-70. PubMed ID: 7685506
    [No Abstract]   [Full Text] [Related]  

  • 15. Histological beta-2-microglobulin amyloidosis 10 years after a successful renal transplantation.
    Jadoul M; Noel H; Malghem J; Galant C; van Ypersele de Strihou C
    Am J Kidney Dis; 1996 Jun; 27(6):888-90. PubMed ID: 8651255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis-related amyloidosis.
    Bardin T; Zingraff J; Kuntz D; Drüeke T
    Nephrol Dial Transplant; 1986; 1(3):151-4. PubMed ID: 3110668
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.
    Kazama JJ; Maruyama H; Gejyo F
    Nephrol Dial Transplant; 2001; 16 Suppl 4():31-5. PubMed ID: 11402095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 2-microglobulin, amyloidosis, and dialysis.
    Acchiardo S
    Int J Artif Organs; 1988 Jul; 11(4):229-31. PubMed ID: 3045017
    [No Abstract]   [Full Text] [Related]  

  • 19. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in understanding dialysis-related amyloidosis.
    Yamamoto S; Kazama JJ; Narita I; Naiki H; Gejyo F
    Bone; 2009 Jul; 45 Suppl 1():S39-42. PubMed ID: 19303954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.